/
ARDS
$0.00-$0.00 (-75.00%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.05
0% from low
Exchange
OTC Link
CS
Borrow rate
231.06%
Hard to borrow
Price (6 mo)
Loading chart…
Change$-7.22
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|---|---|
| Revenue | $2.3M | $860.0K | $2.8M | $1.0M | $1.0M | $0 | $0 |
| Cost of revenue | $1.9M | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross profit | $342.0K | $860.0K | $2.8M | $1.0M | $1.0M | $0 | $0 |
| Gross margin | 15.1% | 100.0% | 100.0% | 100.0% | 100.0% | — | — |
| R&D | $6.3M | $17.4M | $23.0M | $24.1M | $17.0M | $37.9M | $25.9M |
| Operating income | −$7.9M | −$19.7M | −$24.1M | −$29.1M | −$22.4M | −$43.7M | −$30.0M |
| EBITDA | −$7.9M | −$19.7M | −$23.8M | −$28.7M | −$22.1M | −$43.0M | −$29.5M |
| Net income | −$8.4M | −$24.7M | −$22.1M | −$29.7M | −$22.3M | −$42.3M | −$30.7M |
| Net margin | -371.2% | -2867.0% | -801.8% | -2904.2% | -2233.3% | — | — |
| EPS (diluted) | -1.07 | -3.12 | -7.02 | -3.43 | -2.44 | -3.44 | -1.64 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $111M | $3.30 | $3.30–$3.30 | 1 |
| 2027 | $171M | $5.43 | $5.43–$5.43 | 1 |
Forward consensus · source: Financial Modeling Prep
Peer comparison
ARIDIS PHARMACEUTICAL INC
ARIDIS PHARMACEUTICAL INC
Held by traders on TradeandTell
No one on the platform currently holds ARDS.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in ARDS as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded ARDS yet.
